PageOverview.com
 

Websites, domains, hosts that links to levemir.com

Our database shows, that the website levemir.com is linked by a total of 7 websites.

 
Number of websites/domains displayed: 7
Results found: 7
 

Websites discovered:

Home
http://pageoverview.com/website-report/novologmix70-30.com
  • Expected expiration: May 30th in 2018
  • Creation date: May 30th in 2002
  • Renew date: May 13th in 2016
Levemir® (insulin detemir [rDNA origin] injection) HCP Website
http://pageoverview.com/website-report/levemirpro.com
See information about basal insulin & the long-acting insulin from Levemir®. Read Important Safety & Prescribing Info from the Levemir® HCP Website.
  • Expected expiration: October 28th in 2018
  • Creation date: October 28th in 2010
  • Renew date: November 1st in 2016
  • Google Analytics: 44074826-2
Homepage | NovoLog.com
http://pageoverview.com/website-report/novolog.com
Resources about NovoLog® (insulin aspart [rDNA origin] injection), a fast acting mealtime insulin, for people with type 1 or type 2 diabetes. Read Important Safety Information in this page.
  • Expected expiration: March 14th in 2018
  • Creation date: March 13th in 1997
  • Renew date: February 15th in 2016
Levemir® for patients with Diabetes
http://pageoverview.com/website-report/levemir.com
Official website for Levemir® (insulin detemir [rDNA origin] injection), a long-acting insulin used to control high blood sugar. Read Important Safety Information here.
  • Expected expiration: June 24th in 2017
  • Creation date: June 24th in 2002
  • Renew date: May 27th in 2015
Diabetes Care, Management, Treatment & Tips |Cornerstones4Care®
http://pageoverview.com/website-report/cornerstones4care.com
Let Cornerstones4Care® help teach you what diabetes is, how to manage type 2 diabetes, tips for controlling blood sugar levels and more! Learn more today!
  • Expected expiration: September 27th in 2018
  • Creation date: September 27th in 2010
  • Renew date: September 20th in 2016
Xultophy® 100/3.6 | Xultophy® 100/3.6 (insulin degludec and liraglutide injection) 100 units/mL and 3.6 mg/mL
http://pageoverview.com/website-report/xultophy10036.com
Xultophy® 100/3.6 is a medicine that combines insulin degludec and liraglutide. Read important safety information, including Boxed Warning, on this page.
  • Expected expiration: September 26th in 2018
  • Creation date: September 26th in 2016
  • Renew date: September 26th in 2016
Tresiba® Long-Acting Insulin | Tresiba® (insulin degludec injection 100 Units/mL, 200 Units/mL)
http://pageoverview.com/website-report/tresiba.com
Once-daily Tresiba® is a long-acting insulin used to control high blood sugar in adults and children as young as 1 year old with diabetes. Read important safety and prescribing info on this page.
  • Expected expiration: August 27th in 2017
  • Creation date: August 27th in 2010
  • Renew date: September 24th in 2015
0.0104 // 2024-05-07 14:19:39
All Rights reserved 2018 © PageOverview.com